What is the equity of Soligenix this year?
Soligenix has equity of 2.52 M USD this year.
Soligenix Equity 2024
Soligenix Equity
2.52 M USD
Ticker
SNGX
ISIN
US8342233074
WKN
A2AS7Q
In 2024, Soligenix's equity was 2.52 M USD, a -202.12% increase from the -2.47 M USD equity in the previous year.
Soligenix Aktienanalyse
What does Soligenix do?
Soligenix Inc. is a biopharmaceutical company specialized in the development of treatment and prevention methods for serious diseases. It was founded in 1987 and is headquartered in Princeton, New Jersey. The business model of Soligenix Inc. is based on the research and development of innovative therapies for diseases that are currently difficult to treat or have no known cure. The company's research and development focus on three core areas: vaccines, cancer therapies, and rare diseases. In the field of vaccines, Soligenix Inc. has focused on developing therapies against biological threats such as anthrax, smallpox, or botulinum toxin-like toxins. These threats are not only a potential danger to national security but can also occur in the form of natural disasters or terrorist attacks. Soligenix Inc. has several promising vaccine candidates in clinical trials, including an anthrax vaccine that works faster and safer than currently available vaccines. In the field of cancer therapy, the company focuses on developing new immunotherapies for the treatment of solid tumors. Soligenix Inc. uses a technology platform called "RiVax" based on the inactivation of botulinum toxin. This platform has already proven promising in redirecting the body's immune system to tumor cells and killing them. As the last core area, the company is dedicated to the treatment of rare diseases that are often overlooked and insufficiently treated. Soligenix Inc. has already developed a promising candidate for the treatment of oropharyngeal candidiasis (fungal infections in the mouth and throat) and is in phase III clinical trials. Overall, Soligenix Inc. has developed a range of promising products in various stages of clinical trials. In addition to the mentioned candidates, the company has also developed a promising treatment for relieving the side effects of cancer chemotherapy. This product called SGX942 is currently in phase III clinical trials. In addition to ongoing clinical studies, Soligenix Inc. has also established strong partnerships with government organizations such as the US National Institutes of Health or the Biomedical Advanced Research and Development Authority (BARDA). These partnerships are important to secure funding for ongoing research projects and allow the company to bring its products to market quickly. Soligenix Inc. has experienced strong growth in recent years and has established itself as a key player in the biopharmaceutical industry. The company has received several awards for its research work and innovation potential in the past and seems to be on a good path to bring further groundbreaking therapies to the market. Soligenix ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Soligenix's Equity
Soligenix's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Soligenix's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Soligenix's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Soligenix's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Soligenix’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Soligenix stock
What was the equity of Soligenix compared to the previous year?
The equity of Soligenix has increased/decreased by -202.12% decreased compared to the previous year.
What impact does a high equity have on investors of Soligenix?
A high equity is advantageous for investors of Soligenix as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Soligenix?
A low equity can be a risk for investors of Soligenix, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Soligenix affect the company?
An increase in equity of Soligenix can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Soligenix affect the company?
A reduction in equity of Soligenix can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Soligenix?
Some factors that can affect the equity of Soligenix include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Soligenix so important for investors?
The equity of Soligenix is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Soligenix take to change the equity?
To change equity, Soligenix can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Soligenix pay?
Over the past 12 months, Soligenix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Soligenix is expected to pay a dividend of 0 USD.
What is the dividend yield of Soligenix?
The current dividend yield of Soligenix is .
When does Soligenix pay dividends?
Soligenix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Soligenix?
Soligenix paid dividends every year for the past 0 years.
What is the dividend of Soligenix?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Soligenix located?
Soligenix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Soligenix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Soligenix from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.
When did Soligenix pay the last dividend?
The last dividend was paid out on 11/9/2024.
What was the dividend of Soligenix in the year 2023?
In the year 2023, Soligenix distributed 0 USD as dividends.
In which currency does Soligenix pay out the dividend?
The dividends of Soligenix are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Soligenix stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Soligenix
Our stock analysis for Soligenix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Soligenix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
